In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Candel Therapeutics Inc (NASDAQ: CADL) was $7.84 for the day, up 0.90% from the previous closing price of $7.77. In other words, the price has increased by $0.90 from its previous closing price. On the day, 0.94 million shares were traded. CADL stock price reached its highest trading level at $7.96 during the session, while it also had its lowest trading level at $7.3.
Ratios:
Our analysis of CADL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 02, 2022, initiated with a Buy rating and assigned the stock a target price of $11.
On November 19, 2021, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $18.
On August 23, 2021, UBS started tracking the stock assigning a Buy rating and target price of $9.UBS initiated its Buy rating on August 23, 2021, with a $9 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 08 ’25 when Barone Francesca sold 13,673 shares for $8.22 per share. The transaction valued at 112,367 led to the insider holds 124,207 shares of the business.
Schoch Charles sold 9,971 shares of CADL for $81,944 on Jan 08 ’25. The insider now owns 52,549 shares after completing the transaction at $8.22 per share. On Jan 08 ’25, another insider, Tak Paul Peter, who serves as the Chief Executive Officer of the company, sold 21,172 shares for $8.22 each. As a result, the insider received 173,996 and left with 273,616 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 348687936 and an Enterprise Value of 135071536.
Stock Price History:
Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 25.12%, while the 200-Day Moving Average is calculated to be 18.98%.
Shares Statistics:
CADL traded an average of 3.60M shares per day over the past three months and 1565960 shares per day over the past ten days. A total of 32.13M shares are outstanding, with a floating share count of 27.66M. Insiders hold about 37.81% of the company’s shares, while institutions hold 16.09% stake in the company. Shares short for CADL as of 1730332800 were 1779737 with a Short Ratio of 0.85, compared to 1727654400 on 1587686. Therefore, it implies a Short% of Shares Outstanding of 1779737 and a Short% of Float of 8.06.
